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Abstract
Background: Artificial iris anterior chamber implants were originally developed for therapeutic purposes but have
been used recently for the cosmetic alteration of eye colour. There is a growing body of evidence surrounding
their associated risks. We report a case presenting with complications secondary to bilateral NewColorIris® implants,
including the first report of pressure-induced stromal keratopathy in this context.
Case presentation: A thirty-eight year old South American man presented as an emergency in the UK with best
corrected visual acuities of 1/60 OD and 6/18 OS, bilateral corneal decompensation, lens opacities and raised
intraocular pressures 4 years following bilateral NewColorIris® implantation in Panama. Anterior segment optical
coherence tomography demonstrated the direct apposition of the implant with the iris and iridocorneal angle,
together with pressure-induced stromal keratopathy with a fluid interface between the corneal stroma and previous
laser-assisted in situ keratomileusis flaps. We describe the successful combined medical and surgical management
in this case to yield a final visual acuity 6/12 in both eyes.
Conclusion: Artificial iris anterior chamber implants are associated with sight-threatening complications that can
present years after their implantation. We caution against their use for the cosmetic alteration of eye colour.
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Background
Silicone anterior chamber iris implants were first devel-
oped by Kahn in 2004 [1]. Their original intended use
when first presented at the American Academy of Oph-
thalmology meeting was for the treatment of oculocuta-
neous albinism, as well as to improve the iris appearance
of patients with hereditary defects such as iris colobo-
mas or traumatic iris damage. However, they soon be-
came promoted as a cosmetic implant for people
wishing to change their iris colour.
We describe a case of bilateral secondary glaucoma
and severe corneal decompensation four years following
the implantation of NewColorIris® devices in Panama.
This case emphasises the dangers of a procedure adver-
tised as a safe alternative for cosmetic coloured contact
lenses and highlights the fact that sequelae can develop
years after the original surgery.
Case presentation
A thirty eight year old South American man presented
to eye casualty with a four-week history of bilateral pro-
gressive visual loss. His past ophthalmic history includes
laser-assisted in situ keratomileusis (LASIK) five years
previously and cosmetic anterior chamber iris implants
(NewColorIris®) four years prior to presentation. These
operations were performed in Panama. At presentation,
best-corrected visual acuity (BCVA) with glasses was
1/60 (2/60 with pinhole) right eye (OD) and 6/18 (6/9 with
pinhole) left eye (OS). Anterior segment examination
revealed the presence of blue angle-supported iris implants
and bilateral corneal decompensation with stromal
oedema and endothelial pigment deposition (Fig. 1). Intra-
ocular pressure (IOP) at presentation was 40 mmHg in
both eyes and on gonioscopy all angle structures were
obscured by the implants. There were no peripheral
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iridotomies seen. In addition, bilateral lens opacities were
present (left eye lens opacities worse than right).
Anterior segment optical coherence tomography con-
firmed that the iris implants were in direct contact with
both the cornea and iris. Imaging also demonstrated
fluid in the interface between the LASIK flaps and
underlying corneal stroma (Fig. 2).
The patient was immediately commenced on two
hourly G. dexamethasone 0.1 % preservative-free drops
and G. Ganfort® (bimatoprost 0.3 mg/mL and timolol
5.0 mg/mL) once a day to both eyes. He was reviewed
three days later, when his BCVA had reduced to count-
ing fingers (CF) at 1 m OD and 6/36 (6/12 with pinhole)
OS. IOP was recorded at 18 mmHg in both eyes.
After obtaining fully informed consent, the patient
underwent removal of the anterior chamber implants
under general anaesthesia. The implants were removed
through a temporal corneal tunnel. The anterior
chamber was first formed with a cohesive viscoelastic
(Healon®). A 2.75 mm corneal incision was then made.
Two sphincterotomies were performed to facilitate the
folding of the implants. The implants were mobilised,
folded and removed via the wound. The wound was
then secured with 10/0 Nylon sutures after the re-
moval of the viscoelastic.
One week post-operatively, the BCVA remained at CF at
1 m in both eyes due to persistent corneal decompensa-
tion. The IOP in the left eye began to rise despite good
compliance with the drops (from 18 mmHg to 28 mmHg).
G. apraclonodine 0.5 % was commenced three times per
day in the left eye.
The corneal decompensation unfortunately did not im-
prove. With consent, the patient underwent right Descemet
stripping endothelial keratoplasty (DSEK) under general
anaesthesia one month after his initial presentation. He
subsequently underwent left phacoemulsification with
intraocular lens implantation combined with DSEK
under general anaesthesia nine months after his original
presentation. Both operations were uneventful.
At final follow up six months after his left eye surgery,
the patient’s BCVA was 6/12 in the right eye and 6/12 in
the left eye. Both anterior chambers were deep and
quiet, with clear, well-centred grafts (Fig. 3). The IOP
was 11 mmHg OD and 14 mmHg OS. On gonioscopy
the angle was open on 360° inspection in the right eye.
In the left eye there were 270° of broad peripheral anter-
ior synechiae (PAS). Fundus examination showed a
healthy optic disc in the right eye with a cup:disc (C:D)
ratio of 0.2 and healthy neuroretinal rim. The left eye
however did show evidence of neural rim loss mainly su-
periorly with a C:D ratio of 0.7. The patient was being
maintained on G. dexamethasone 0.1 % drops once a
day to each eye and G. timolol 0.5 % twice a day to the
left eye.
Fig. 1 Anterior chamber slit lamp image. The implant is seen
covering the entire iris, with signs of corneal decompensation
Fig. 2 Optical coherence tomography of the right eye showing the position of the iris implant in direct contact with underlying iris tissue and
obstructing the iridocorneal angle. Fluid is demonstrated in the interface between the LASIK flap and underlying corneal stroma
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Conclusions
The cosmetic use of intraocular implants is a relatively
new phenomenon in the UK [2]. Although there are no
robust studies assessing the long-term safety and efficacy
of these implants, there have been a growing number of
case reports and case series highlighting the dangers of
artificial iris anterior chamber implants [2–10]. These in-
clude the permanent structural damage of the corneal
endothelium causing corneal decompensation [8], complete
stromal atrophy of iris adjacent to NewColorIris® implants
[9], uveitis, central retinal vein occlusion, uncontrolled rise
in IOP and secondary glaucoma [8]. The biggest case series
to date was published by Hoguet, et al [7], who report on
14 eyes, 7 (50 %) of which had a raised IOP at presentation.
The majority could not be managed with topical treatment
alone and required surgical intervention with either
trabeculectomy or aqueous drainage devices. A re-
view by Sikder, et al found that 81.25 % of phakic eyes
developed corneal oedema following NewColorIris® im-
plantation [10].
The NewColorIris® is a single-piece silicone implant. It
is single-sized with a diameter of 15 mm, a central
pupillary aperture of 4.5 mm and 0.16 mm thickness [1].
The implant is folded and inserted through a 2.8 mm
corneal incision. It is unfolded in the anterior chamber
and positioned directly above the iris. The implant has
six foot processes to secure its position and in theory
only partially occlude the angle [11]. The implant is cir-
cular and it is therefore anticipated that it is not sup-
ported in a uniform way within the anterior chamber
given the anatomical asymmetry between vertical and
horizontal meridians [10]. Anderson, et al have demon-
strated vaulting of implants in the anterior chamber [5]
and there are also concerns over changing implant pos-
ition over time [10].
Angle supported anterior chamber implants have been
in use since the 1950’s for the correction of aphakia [12].
They are well known to cause rises in IOP, reportedly in
up to 75 % of patients [10]. The direct implant contact
with the iris results in continuous mechanical damage
and pigment dispersion. The liberated pigment conse-
quently occludes the trabecular meshwork and leads to
rises in IOP. Castanera et al also reported surface irregu-
larities of the NewColorIris® implants on electron mi-
croscopy. These irregularities can further exacerbate the
dispersion of iris pigment and may contribute to endo-
thelial cell damage [13]. The implant can also cause
pupillary block if no prophylactic peripheral iridotomy is
performed at the time of implantation. In our case, we
hypothesise that the rise in IOP was due to a combin-
ation of pigment dispersion and mechanical trabecular
meshwork damage resulting from the direct apposition
of the implant with iridocorneal angle structures. These
mechanisms have also been documented by other
authors [2–5,13]. This is likely to have induced the
formation of PAS in the left eye, contributing to con-
tinued rises in IOP despite implant removal. The pig-
ment dispersion observed in both eyes improved
post-operatively.
In all published case reports, implants were surgically
explanted. Sikder and co-authors emphasise the import-
ance of minimising intraoperative trauma to the iris, lens
and corneal endothelium. They describe a surgical tech-
nique for NewColorIris® implant removal that involves
cutting the implant into three equal segments and re-
moving each through a 2.75 mm temporal clear corneal
incision [14]. Despite careful explantation, the damage
induced by artificial iris anterior chamber implants can
be permanent. Our patient developed secondary corneal
endothelial cell loss, glaucoma and cataracts as a result
of NewColorIris® implants, as well as pressure-induced
stromal keratopathy (PISK) (Fig. 2). The latter complica-
tion has not been described previously in this context
and to the best of our knowledge is unique in our pa-
tient. PISK is a rare condition affecting eyes that have
undergone lamellar corneal refractive surgery [15]. In
this case, the patient underwent LASIK one year prior to
NewColorIris® implantation and PISK occurred second-
ary to endothelial cell failure and high IOP. An import-
ant consideration is the purported underestimation of
IOP by applanation tonometry in the prescence of inter-
face fluid [16]. A complete resolution of interface fluid
was observed in both eyes following topical IOP-
lowering treatment, iris implant removal and subsequent
combined phacoemulsification with intraocular lens in-
sertion and DSEK.
This case adds to the literature by highlighting the
long-term sight-threatening sequelae of NewColorIris®
implants. There has been increasing interest in recent
years over the cosmetic use of these implants, with the
procedure being advertised by informal websites with a
lack of medical review or published evidence to support
Fig. 3 Post-operative view of the right eye. The anterior chamber is
deep with a clear cornea post-DSEK
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their safety [17]. We caution against their use for the
cosmetic alteration of iris colour.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
images. A copy of the written consent is available for
review by the Editor of this journal.
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